SNY : Summary for Sanofi American Depositary Shar - Yahoo Finance

U.S. Markets closed

Sanofi (SNY)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
40.21-0.14 (-0.35%)
At close: 4:02PM EST

40.12 -0.09 (-0.23%)
After hours: 5:19PM EST

People also watch
NVSGSKAZNLLYNVO
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close40.35
Open40.33
Bid0.00 x
Ask0.00 x
Day's Range39.91 - 40.35
52 Week Range36.81 - 44.50
Volume2,106,309
Avg. Volume2,203,803
Market Cap100.6B
Beta0.83
PE Ratio (TTM)23.37
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.66 (4.12%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Investopedia7 hours ago

    Failed Mergers Cast Shadow on Sanofi's Future

    Two failed acquisitions have cast a long shadow on Sanofi's prospects.

  • 5 Stupendously Expensive Cancer Drugs
    Motley Fool8 hours ago

    5 Stupendously Expensive Cancer Drugs

    Cancer drug costs routinely eclipse the six-figure mark, but the prices of these cancer drugs are truly eye-popping.

  • Reuters4 days ago

    Sanofi's M&A misses frustrate some investors in drugmaker

    PARIS/DAVOS, Switzerland (Reuters) - For the last year, Sanofi's chief executive has made clear his quest for deals to help revive the fortunes of France's biggest drugmaker. Olivier Brandicourt's failure to land two big biotech acquisitions he was chasing has led to growing impatience among some investors. In an interview at the World Economic Forum in the Swiss resort of Davos this week Brandicourt defended his track record, citing an unwillingness to overpay for pricey assets and a paucity of good opportunities.